Entities / Company
ANI Pharmaceuticals (United States).
company in Baudette, United States
- Reports this week
- 0
- Active events
- 1
- Connections
- 47
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Active this week
Gone quiet
No new reports in 90+ days-
FDA approved prefilled syringe of Cortrophin Gel, noting strong uptake and concurrent discussion of Trump-era tariffs.Some support1 report
-
ANI Pharmaceuticals tested Iluvien in a clinical trial for Diabetic Macular Oedema, comparing it against aflibercept.Some support2 reports
-
Both HCA Corporation and ANI Pharmaceuticals were noted as medical stocks with positive ESP figures on July 31, 2025.Some support1 report
-
Bristol-Myers Squibb and ANI Pharmaceuticals are both companies operating within the pharmaceuticals segment.Some support4 reports
-
ANI Pharmaceuticals surpassed analyst estimates and raised financial guidance on August 9, 2025.Some support2 reports
-
ANI Pharmaceuticals reported strong Q3 results, noting rapid growth in its Rare Disease business and increased guidance.Well supported8 reports
-
ANI Pharmaceuticals achieved a Zacks Rank of #1 and a Momentum Style Score of A based on its stock performance compared to its industry benchmark.Some support5 reports
-
ANI Pharmaceuticals is scheduled to present at a conference involving H.C. Wainwright and Morgan Stanley, led by CEO Nikhil Lalwani.Some support3 reports
No events began in the chosen period. Widen it, or reset.
Around ANI Pharmaceuticals (United States) this week
News at the entities that move ANI Pharmaceuticals (United States) most-
Massachusetts General Hospital OperationalSolid Biosciences received FDA approval for a gene therapy trial on July 9, 2025.Moves ANI Pharmaceuticals (United States)
Connections
The 1 strongest of 47, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Massachusetts General Hospital Operational
ANI Pharmaceuticals is conducting a Phase IV clinical trial at Massachusetts General Hospital.
History
Events by the month they beganJune 2026
9 events- Trump's pledge to unleash oil and gas benefits stocks, involving Willis Towers Watson.
- FDA approved prefilled syringe of Cortrophin Gel, noting strong uptake and concurrent discussion of Trump-era tariffs.
- ANI Pharmaceuticals tested Iluvien in a clinical trial for Diabetic Macular Oedema, comparing it against aflibercept.
- Both HCA Corporation and ANI Pharmaceuticals were noted as medical stocks with positive ESP figures on July 31, 2025.
- Bristol-Myers Squibb and ANI Pharmaceuticals are both companies operating within the pharmaceuticals segment.
- ANI Pharmaceuticals surpassed analyst estimates and raised financial guidance on August 9, 2025.
- ANI Pharmaceuticals reported strong Q3 results, noting rapid growth in its Rare Disease business and increased guidance.
- ANI Pharmaceuticals achieved a Zacks Rank of #1 and a Momentum Style Score of A based on its stock performance compared to its industry benchmark.
- ANI Pharmaceuticals is scheduled to present at a conference involving H.C. Wainwright and Morgan Stanley, led by CEO Nikhil Lalwani.